The FDA approved several therapies in oncology in the month of March 2025. These drugs included treatments for ...

BeiGene’s Tevimbra (tislelizumab) has been recommended by the European Medicines Agency’s human medicines committee as part of a first-line combination treatment for an aggressive form of lung cancer.

Pat Gulhati, MD, PhD, discusses findings from a comprehensive analysis of genetic, immunological, and signaling pathway variations in pancreatic cancer.

On March 5, 2025, the FDA cleared an investigational new drug application for CTD402, a CD7-targeted universal CAR T-cell therapy, for the treatment of pediatric and adult patients with ...

Here is a roundup of March 2025 U.S. FDA approvals across cancer subtypes, including prostate, bladder and gastrointestinal ...

Merus leads biotech with its innovative antibody platforms, strong financials, and promising petosemtamab targeting cancer.

Almost all cases are caused by human papillomavirus (HPV) infection, with approximately 80% classified as squamous cell carcinoma ... 22% with adenocarcinoma or adenosquamous carcinoma ...

Laryngeal cancer affects the larynx (voice box) and often can be curable. Here are the treatment and surgical options and how ...

How do dermatologists diagnose squamous cell skin cancer? When you see a board-certified dermatologist for a spot that might be skin cancer, your dermatologist will examine your skin carefully. If ...

Anal cancer is a rare type of cancer that affects the anus (the opening through which stool leaves the body) or nearby areas, from the skin just outside the anus to the canal that connects the anus to ...